Stay updated on Safety Efficacy HMI-203 in MPS II Clinical Trial

Sign up to get notified when there's something new on the Safety Efficacy HMI-203 in MPS II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety Efficacy HMI-203 in MPS II Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T04:07:30.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed descriptions of a Phase 1 study for HMI-203 gene therapy for Mucopolysaccharidosis II, while a new revision number has been added.
    Difference
    21%
    Check dated 2025-04-23T19:13:35.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T11:40:22.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:55:22.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T22:09:24.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    1%
    Check dated 2025-02-10T14:48:42.000Z thumbnail image

Stay in the know with updates to Safety Efficacy HMI-203 in MPS II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety Efficacy HMI-203 in MPS II Clinical Trial page.